Myriad Genetics Inc Live Stock Price Today, Share Analysis and Chart

Name: Myriad Genetics, Inc.: Is Infosys Ltd. worth buying?
Item: Myriad Genetics, Inc.
Rating: 1.89659725
Author: Trendlyne DVM scores

Expensive Performer

about

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its...

3.96 -0.05 (-1.25%)

53.90% Fall from 52W High

769.8K

XNAS Volume

XNAS 22 Sep, 2026 11:38 AM (EDT)

Medium Financial Strength

38.9 / 100

Expensive Valuation

27.5 / 100

Technically Neutral

46.5 / 100

Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM

1Yr Price target downside is -15%

9 analysts

Myriad Genetics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Myriad Genetics Inc Live Stock Price Today, Share Analysis and Chart

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its...

53.90% Fall from 52W High

SWOT Analysis

Myriad Genetics Inc Live Price Chart

Myriad Genetics Inc Live Price Chart